ALHC
Alignment Healthcare, Inc. · Healthcare · Medical - Healthcare Plans
Señales de momentum (gestores comparables): amplitud de titulares 0.0% · flujo de acciones -14.0% · nuevas posiciones netas 0.0% — fórmula
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q1 2025
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q2 2026 | 105 | -3 | 153.28M | $3.65B | +9 | −12 |
| Q1 2026 | 111 | +15 | 140.61M | $2.43B | +19 | −5 |
| Q4 2025 | 96 | +1 | 127.62M | $2.52B | +2 | — |
| Q3 2025 | 20 | +1 | 84.25M | $1.47B | +1 | −1 |
| Q2 2025 | 17 | 0 | 71.35M | $998.91M | +1 | −1 |
| Q1 2025 | 14 | 0 | 21.82M | $406.29M | +2 | −2 |
| Q4 2024 | 14 | +3 | 25.36M | $285.33M | +3 | — |
| Q3 2024 | 10 | +1 | 10.84M | $128.16M | +2 | −1 |
| Q2 2024 | 9 | — | 12.27M | $95.98M | — | — |
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Wellington Management ✦ | 7.51M | +0.9% | $139.82M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 2 | Wellington Management ✦ | 7.51M | +0.9% | $139.82M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 3 | Wellington Management ✦ | 7.51M | +0.9% | $139.82M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 4 | Wellington Management ✦ | 7.51M | +0.9% | $139.82M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 5 | Geode Capital Management ✦ (pasivo) | 2.49M | +2.1% | $46.44M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 6 | Geode Capital Management ✦ (pasivo) | 2.49M | +2.1% | $46.44M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 7 | State Street Global Advisors ✦ (pasivo) | 2.40M | -0.1% | $44.76M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 8 | Millennium Management ✦ | 2.36M | -30.3% | $43.97M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 9 | T. Rowe Price ✦ | 2.20M | +9.7% | $40.95M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 10 | T. Rowe Price ✦ | 2.20M | +9.7% | $40.95M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 11 | Renaissance Technologies ✦ | 2.06M | +16.3% | $38.31M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 12 | Arrowstreet Capital ✦ | 1.04M | +604.7% | $19.35M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 13 | Marshall Wace ✦ | 746.30K | Nuevo | $13.90M | 0.0% | New | 1 | SEC ↗ |
| 14 | Marshall Wace ✦ | 746.30K | Nuevo | $13.90M | 0.0% | New | 1 | SEC ↗ |
| 15 | AQR Capital Management ✦ | 297.32K | -14.0% | $5.54M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 16 | AQR Capital Management ✦ | 297.32K | -14.0% | $5.54M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 17 | AQR Capital Management ✦ | 297.32K | -14.0% | $5.54M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 18 | AQR Capital Management ✦ | 297.32K | -14.0% | $5.54M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 19 | AQR Capital Management ✦ | 297.32K | -14.0% | $5.54M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 20 | Citadel Advisors ✦ | 244.27K | -92.1% | $4.55M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 21 | Norges Bank ✦ (pasivo) | 185.84K | -38.2% | $3.46M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 22 | D. E. Shaw & Co. ✦ | 176.24K | -4.5% | $3.28M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 23 | Adage Capital Partners ✦ | 69.50K | +101.5% | $1.29M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 24 | Gotham Asset Management ✦ | 35.57K | Nuevo | $662,276 | 0.0% | New | 1 | SEC ↗ |
«Su ponderación» = la participación de la posición en el valor de renta variable 13F declarado por ese gestor — la medida de convicción. ✦ = gestor seleccionado.
Nuevos compradores
| Marshall Wace | $13.90M | 0.0% |
| Marshall Wace | $13.90M | 0.0% |
| Gotham Asset Management | $662,276 | 0.0% |
Posición cerrada
| Point72 Asset Management | $20.09M | era 0.1% |
| Two Sigma Investments | $257,625 | era 0.0% |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 1 tenedores, 55.50K acciones, $977 declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Qué otros valores suelen tener también los tenedores rastreados de este activo — recuentos de cotenencia, no relaciones fundamentales.
Compras en mercado abierto (P)
Sin compras en mercado abierto por parte de insiders en nuestra ventana de cobertura.
Ventas en mercado abierto (S)
Officer · 5.00K acc. · $70,000
Officer, Director · 298.00K acc. · $4.14M
Las adjudicaciones, ejercicios y retenciones fiscales nunca se contabilizan aquí como compras o ventas. Metodología